Brain Tumor Clinical Trial
Official title:
Linking Day-to-day Digital Behaviour Captured on the Smartphone With Brain Function in Patients Undergoing Brain Surgery - the "Smart Surgery" Study
This study will thus examine daily behaviour based on smartphone use and link it to the
neurological and neuropsychological status as well as to neuroradiological studies that are
part of the clinical routine. The study will examine behaviour changes before and after
surgery, and how this change in measured behaviour with the smartphone relates to today's
"gold standard", namely professional neuropsychological examination and quantification of
brain damage on imaging studies (MRI).
This study is a proof-of-principle study that intends to build the basis for larger future
observational studies on patients with focal or diffuse brain pathologies.
Pathologies of the central nervous system (CNS), as well as their surgical treatment, may
interfere with the physiological and behavioural functions of the human brain. Commonly,
before and after surgical treatment, the neurosurgeon examines the patient carefully for
neurological deficits and additionally asks neuropsychologists to evaluate higher cognitive
functions. These examinations, however, only represent the situation at a given point in
time, and currently longitudinal or continuous evaluation of physiological and behavioural
functions of the human brain is highly limited. Furthermore, in the conventional examinations
the complex human behaviour is reduced to very simplified scores (e.g. the NIHSS for
neurological or MoCA for neuropsychological functioning). Fluctuations in physiological and
behavioural functions are very likely, but are unlikely to be captured with current
evaluations at single (discrete) pre- and postoperative points in time. To date, "on-line"
continuous evaluation of brain function in patients undergoing (potentially risky)
neurosurgical procedures has not been established.
The touchscreen interface of smartphones offers a fresh avenue to capture day-to-day
behaviour (engagement of finger tips) by exploiting the technology intrinsic to a smartphone.
For instance, the speed of touchscreen use, the distinct behavioural contexts
(compartmentalised into Apps) and the corresponding habits can be seamlessly and
non-obtrusively captured. More importantly, compared with current discrete approaches of
evaluation, this continuous approach can account for - and even exploit - the natural
fluctuations in brain functions.
Nevertheless, behavioural data from touchscreens is new to scientific exploration and various
fundamental questions remain to be answered, such as what are the basic statistical features
of smartphone behaviour, how does this behaviour vary from one day to another, and how does
this behaviour reflect basic demographic information? This gap in our understanding of
smartphone behavioural data also implies that the exact statistical methods to be employed
may need to undergo adjustments. For instance, the common central tendency measure of the
sample mean may be highly unstable if the parameter/s occupy a power-law distribution rather
than a Poisson or Gaussian distribution. In summary, ever-new exploration of the neuroscience
of touchscreen behaviour must trigger the right choice of analytical and statistical methods.
The focus of this study is laid on patients with pathologies of the CNS. The investigators
aim to examine both patients with diffuse and focal pathologies. In order to study diffuse
pathologies, the investigators will include patients with hydrocephalus. In order to study
focal pathologies, the investigators will include patients with brain tumours or
arteriovenous malformations (AVMs) - which are localised and described using clinical
neuroimaging. Patients will be examined before and after a neurosurgical procedure.
At the "UniversitätsSpital Zürich", both patients with hydrocephalus that are scheduled for
ventriculo-peritoneal (VP)-shunting and patients with brain tumours/AVMs that are scheduled
for microsurgical resection routinely undergo a neurosurgical, neuropsychological and
neuroradiological examination (by MRI) preoperatively and at 3 months postoperative (for
clinical purpose). Patients that agree to participate in this study will install a free App
(programmed by the University of Zurich (UZH) spin-off QuantActions and freely available on
the Google Play store) on their smartphone that records their day-to-day physiological and
behavioural status associated with use of the hand (smartphone touchscreen). The study will
examine behaviour changes before and after surgery, and how this change in measured behaviour
with the smartphone relates to the neuropsychological examination and quantification of brain
damage on imaging studies (MRI).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05023434 -
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors
|
||
Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
Completed |
NCT02768389 -
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
|
Early Phase 1 | |
Terminated |
NCT01902771 -
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
|
Phase 1 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Recruiting |
NCT03286335 -
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
|
N/A | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Recruiting |
NCT05358340 -
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
|
N/A | |
Recruiting |
NCT03276676 -
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
|
Phase 2 | |
Completed |
NCT02851355 -
Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway
|
||
Completed |
NCT02558569 -
The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block
|
Phase 4 | |
Completed |
NCT02713087 -
Vasopressor Effects in Anesthetized Patients
|
Phase 4 | |
Completed |
NCT02409121 -
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
|
N/A | |
Withdrawn |
NCT02165995 -
Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery
|
N/A | |
Terminated |
NCT02674945 -
Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase
|
||
Withdrawn |
NCT01202539 -
Real-time Assessment of Frameless Intrafraction Motion
|
||
Completed |
NCT01171469 -
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
|
Phase 1 | |
Terminated |
NCT01044966 -
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
|
Phase 1/Phase 2 | |
Completed |
NCT00760409 -
Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI
|
N/A | |
Completed |
NCT00503204 -
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
|
Phase 1 |